Pfizer and its German companion firm BioNtech will apply for emergency authorization for his or her COVID-19 vaccine on Friday, Well being and Human Providers Secretary Alex Azar mentioned Thursday.
Azar made the announcement throughout a uncommon public look of the White Home coronavirus activity power.
The software would come simply two days after the businesses introduced that closing efficacy information on their vaccine candidate confirmed it to be 95 % efficient.
Pfizer final week mentioned that interim information revealed its vaccine to be 90 % efficient.
The announcement from BioNTech/Pfizer, adopted this week by one from rival Moderna of a equally efficient vaccine candidate, raised hopes that management of the virus and an finish to the pandemic may very well be in sight.
Azar mentioned he expects Moderna to file for emergency use shortly.
Relying on how shortly the overview course of takes, extraordinarily restricted preliminary doses may very well be administered to folks like front-line well being staff and different important personnel earlier than the top of the 12 months. Nonetheless, it doubtless will not be till subsequent spring or summer time that there are sufficient doses of vaccines accessible for widespread distribution.
Azar on Thursday mentioned between the 2 vaccine candidates, the U.S. expects to have 40 million doses accessible by the top of the 12 months, which is sufficient to vaccinate about 20 million folks.
Proper now, america is averaging greater than 1 million new infections per week.